Dental practices in England are set to reopen on Monday, June 8, but there has been widespread concern about how guidance has been released to the sector, and some anger over the timing of the reopening which, HBI hears, may be too soon.
Small and medium healthcare facilities across Sub-Sarahan Africa are facing liquidation with Africa Healthcare Federation reporting an average 40% revenue drop in March. Even the maternity sector, which has held steady in Europe, has seen fewer admissions in Kenya.
Spain's dental clinics are re-opening with infection control protocols after being largely closed for months, but the market is expected to shrink by 20% in 2020. On top of the dealing with the COVID-19 pandemic, the largest players have been busy re-shuffling their boards and striking agreements with creditors.
Regulatory body Public Health England (PHE) has ordered telehealth player Babylon to stop selling B2C antibody tests until it has established their accuracy. Supplier Abbott has already said that the test is not suitable for home sample collection but players are still scrambling to sell in what's likely to be a multi-billion market.
Ping An's early-stage investment arm Voyager Fund has invested in Berlin-based dental healthtech group PlusDental. We examine PlusDental's business model and talk to CEO Peter Baumgart who says demand has surged back in DACH.
The Irish government is reportedly considering buying and nationalising some of the country's 19 private hospitals to help increase bed capacity in the public system. HBI talks to public and private hospital sources for and against it.
Microsoft has selected Polish start-up Infermedica to provide the symptom-checking solution on the chatbot that it sells B2B to healthcare providers and payors. HBI speaks to CEO Piotr Orzechowski.
COVID-19 could accelerate the push towards home haemodialysis and increased operator costs are unlikely to be reflected in revised tariffs, Fresenius Medical Care's global head of M&A Dr Wolfgang Hofmann tells HBI.
Italian industrial and medical gas group Sapio has entered France's medicalised homecare sector with the acquisition of one of the ten largest for-profit providers. It is the latest in a string of transactions in the space including by some left-field buyers.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.